NASDAQ · Financial Statements

Sotera Health Company (SHC) Revenue, Earnings & Financial Statements

$16.05 NASDAQ: SHC Market Cap $4.58B

Data as of Nov 17, 2026 close · Statements through the quarter ended Sep 2026 · Source: Financial Modeling Prep (methodology)

Sotera Health Company most recently reported annual revenue of $1.2B, net profit of $78.0M. Revenue grew at an average annual rate of 7.3% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Sotera Health Company: Revenue rose from $746.0M in 2018 to $1.2B in 2025, a change of +56.0% over 7 years; net profit was positive in 4 of 8 reported years; operating margin moved from 10.8% to 33.8%, a shift of +22.9 percentage points; the most recent year shows net profit of $78.0M.

Income Statement — 8 Years (USD millions)

Metric20182019202020212022202320242025
Revenue$746.0M$778.0M$818.0M$931.0M$1.0B$1.0B$1.1B$1.2B
Operating Expenses$665.0M$595.0M$612.0M$675.0M$755.0M$773.0M$803.0M$771.0M
Operating Profit$81.0M$184.0M$206.0M$257.0M$248.0M$277.0M$298.0M$393.0M
Operating Margin10.8%23.6%25.2%27.6%24.7%26.4%27.1%33.8%
Other Income−$57.0M−$185.0M−$245.0M−$81.0M−$491.0M−$171.0M−$184.0M−$245.0M
Interest$143.0M$158.0M$215.0M$74.0M$80.0M$143.0M$165.0M$156.0M
Depreciation$147.0M$147.0M$144.0M$151.0M$146.0M$158.0M$164.0M$139.0M
Profit Before Tax$24.0M−$1.0M−$39.0M$176.0M−$243.0M$106.0M$114.0M$148.0M
Tax rate (%)124.3%-2129.8%3.5%33.4%3.9%51.5%61.0%47.2%
Net Profit−$6.0M−$21.0M−$39.0M$117.0M−$234.0M$51.0M$44.0M$78.0M
EPS−$0.02−$0.07−$0.14$0.41−$0.83$0.18$0.16$0.27

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricDec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26Sep '26
Revenue$310.0M$248.0M$277.0M$285.0M$290.0M$255.0M$294.0M$311.0M$303.0M$280.0M$321.0M$325.0M
Operating Expenses$206.0M$195.0M$200.0M$205.0M$203.0M$197.0M$206.0M$200.0M$167.0M$193.0M$215.0M$211.0M
Operating Profit$104.0M$53.0M$77.0M$81.0M$87.0M$57.0M$88.0M$111.0M$136.0M$87.0M$107.0M$114.0M
Operating Margin33.5%21.4%27.8%28.2%30.0%22.4%30.0%35.7%44.9%30.9%33.2%35.0%
Interest$43.0M$42.0M$40.0M$42.0M$41.0M$41.0M$41.0M$39.0M$35.0M$35.0M$34.0M$34.0M
Profit Before Tax$66.0M$11.0M$15.0M$43.0M$45.0M−$15.0M$19.0M$73.0M$70.0M$43.0M$78.0M$84.0M
Tax rate (%)41.1%42.6%42.2%60.2%72.6%10.5%57.9%33.6%50.6%37.6%31.3%30.3%
Net Profit$39.0M$6.0M$9.0M$17.0M$12.0M−$13.0M$8.0M$48.0M$35.0M$27.0M$54.0M$58.0M
EPS$0.14$0.02$0.03$0.06$0.04−$0.05$0.03$0.17$0.12$0.09$0.19$0.20

Over the 8 years reported for Sotera Health Company, borrowings increased from $2.2B in 2018 to $2.3B in 2025, cash stood at $346.0M in the latest year, shareholders' equity was $3.0M, current assets covered current liabilities 2.45 times.

Balance Sheet — 8 Years (USD millions)

Metric20182019202020212022202320242025
Total Assets$2.7B$2.6B$2.8B$2.8B$3.1B$3.1B$3.1B$3.3B
Current Assets$313.0M$252.0M$315.0M$346.0M$645.0M$557.0M$526.0M$613.0M
Cash$96.0M$63.0M$102.0M$107.0M$395.0M$296.0M$277.0M$346.0M
Inventory$38.0M$37.0M$34.0M$54.0M$37.0M$48.0M$49.0M$59.0M
Receivables$142.0M$112.0M$131.0M$134.0M$156.0M$176.0M$166.0M$176.0M
Fixed Assets$586.0M$582.0M$656.0M$691.0M$801.0M$971.0M$1.1B$1.2B
Capital Work in Progress$0$0$0$0$0$0$0$0
Investments$0$0$13.0M$9.0M$0$0$0$0
Other Assets$1.0B$1.0B$1.1B$1.1B$1.1B$1.1B$1.1B$1.1B
Total Liabilities$2.7B$3.2B$2.3B$2.2B$2.8B$2.7B$2.7B$2.7B
Current Liabilities$143.0M$124.0M$141.0M$161.0M$792.0M$231.0M$191.0M$250.0M
Borrowings$2.2B$2.8B$1.9B$1.8B$2.0B$2.3B$2.4B$2.3B
Other Liabilities$425.0M$373.0M$397.0M$376.0M$735.0M$360.0M$316.0M$384.0M
Equity$2.0M$2.0M$3.0M$3.0M$3.0M$3.0M$3.0M$3.0M
Reserves$44.0M−$643.0M$452.0M$586.0M$350.0M$444.0M$405.0M$606.0M

For Sotera Health Company, operating cash flow was positive in 7 of 8 reported years; free cash flow in the latest year was $149.0M; free cash flow was positive in 7 of 8 years; financing activities used $8.0M in the latest year, which covers debt repayment, dividends and buybacks.

Cash Flow Statement — 8 Years (USD millions)

Metric20182019202020212022202320242025
Operating Cash Flow$120.0M$149.0M$121.0M$282.0M$278.0M−$148.0M$224.0M$287.0M
Investing Cash Flow$24.0M−$115.0M−$212.0M−$262.0M−$364.0M−$430.0M−$358.0M−$273.0M
Financing Cash Flow−$1.0M−$18.0M−$55.0M−$17.0M−$2.0M−$32.0M−$39.0M−$8.0M
Net Cash Flow$21.0M−$34.0M$39.0M$4.0M$289.0M−$95.0M−$23.0M$68.0M
Free Cash Flow$47.0M$92.0M$67.0M$179.0M$96.0M−$363.0M$45.0M$149.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.13
EV / EBITDA12.08
FCF Yield2.89%
Quick Ratio2.89
Interest Coverage3.20
Return 1Y3.75%
Return 3Y20.36%
Return 5Y-28.71%

Sotera Health Company (SHC) financials — frequently asked questions

What is Sotera Health Company's annual revenue?

Sotera Health Company (SHC) reported annual revenue of $1.2B in its most recent fiscal year.

What is Sotera Health Company's net profit?

Sotera Health Company (SHC) reported net profit of $78.0M in its most recent fiscal year.

What is SHC EV/EBITDA?

Sotera Health Company's enterprise value to EBITDA (EV/EBITDA) ratio is 12.08.

Revenue and earnings of other Medical - Diagnostics & Research stocks

TMO revenue $44.6BDHR revenue $24.6BIDXX revenue $4.3BA revenue $6.9BWAT revenue $3.2BIQV revenue $16.3BNTRA revenue $2.3BMTD revenue $4.0BILMN revenue $4.3BLH revenue $14.0BAll Medical - Diagnostics & Research stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
SHC Overview SHC Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.